Published in JMIR Public Health Surveill on May 17, 2016
Rates of Primary and Secondary Syphilis Among White and Black non-Hispanic Men Who Have Sex with Men, US States, 2014. J Acquir Immune Defic Syndr (2017) 0.75
Estimating the population size of men who have sex with men in the United States to obtain HIV and syphilis rates. Open AIDS J (2012) 4.20
Estimating the number of persons who inject drugs in the united states by meta-analysis to calculate national rates of HIV and hepatitis C virus infections. PLoS One (2014) 1.69
Rates of Prevalent HIV Infection, Prevalent Diagnoses, and New Diagnoses Among Men Who Have Sex With Men in US States, Metropolitan Statistical Areas, and Counties, 2012-2013. JMIR Public Health Surveill (2016) 1.29
Estimating the Population Sizes of Men Who Have Sex With Men in US States and Counties Using Data From the American Community Survey. JMIR Public Health Surveill (2016) 1.24
Population Size Estimates for Men who Have Sex with Men and Persons who Inject Drugs. J Urban Health (2015) 1.21
Estimating the Number of Heterosexual Persons in the United States to Calculate National Rates of HIV Infection. PLoS One (2015) 0.89
Estimated HIV incidence in the United States, 2006-2009. PLoS One (2011) 13.03
Changes in sexual behavior and risk of HIV transmission after antiretroviral therapy and prevention interventions in rural Uganda. AIDS (2006) 9.45
Cancer risk in people infected with human immunodeficiency virus in the United States. Int J Cancer (2008) 6.13
Assessment of a pilot antiretroviral drug therapy programme in Uganda: patients' response, survival, and drug resistance. Lancet (2002) 5.80
Differences in human immunodeficiency virus care and treatment among subpopulations in the United States. JAMA Intern Med (2013) 5.39
Adherence to antiretroviral therapy in a home-based AIDS care programme in rural Uganda. Lancet (2006) 5.34
Cancer burden in the HIV-infected population in the United States. J Natl Cancer Inst (2011) 4.69
Prevalence, incidence and mortality associated with tuberculosis in HIV-infected patients initiating antiretroviral therapy in rural Uganda. AIDS (2007) 4.52
The costs and effectiveness of four HIV counseling and testing strategies in Uganda. AIDS (2009) 4.45
Screening tests to detect Chlamydia trachomatis and Neisseria gonorrhoeae infections--2002. MMWR Recomm Rep (2002) 4.44
Rates of virological failure in patients treated in a home-based versus a facility-based HIV-care model in Jinja, southeast Uganda: a cluster-randomised equivalence trial. Lancet (2009) 4.33
Undiagnosed HIV prevalence among adults and adolescents in the United States at the end of 2006. J Acquir Immune Defic Syndr (2010) 4.32
The estimated direct medical cost of sexually transmitted diseases among American youth, 2000. Perspect Sex Reprod Health (2004) 3.95
Population-based hematologic and immunologic reference values for a healthy Ugandan population. Clin Diagn Lab Immunol (2004) 3.92
Transmission of human herpesvirus 8 by blood transfusion. N Engl J Med (2006) 3.80
Asymptomatic serum cryptococcal antigenemia and early mortality during antiretroviral therapy in rural Uganda. Trop Med Int Health (2007) 3.69
Reproductive intentions and outcomes among women on antiretroviral therapy in rural Uganda: a prospective cohort study. PLoS One (2009) 3.66
Vital Signs: HIV diagnosis, care, and treatment among persons living with HIV--United States, 2011. MMWR Morb Mortal Wkly Rep (2014) 3.60
HIV transmission risk behavior among HIV-infected adults in Uganda: results of a nationally representative survey. AIDS (2008) 3.52
Unfinished business--expanding HIV testing in developing countries. N Engl J Med (2006) 3.48
Performance of immunologic responses in predicting viral load suppression: implications for monitoring patients in resource-limited settings. J Acquir Immune Defic Syndr (2006) 3.38
Disclosure of HIV status and adherence to daily drug regimens among HIV-infected children in Uganda. AIDS Behav (2006) 3.18
Estimating HIV incidence in the United States from HIV/AIDS surveillance data and biomarker HIV test results. Stat Med (2008) 2.90
Comparison of home and clinic-based HIV testing among household members of persons taking antiretroviral therapy in Uganda: results from a randomized trial. J Acquir Immune Defic Syndr (2010) 2.83
Processes and outcomes of HIV serostatus disclosure to sexual partners among people living with HIV in Uganda. AIDS Behav (2007) 2.78
Implementing an HIV and sexually transmitted disease screening program in an emergency department. Ann Emerg Med (2006) 2.68
Routine intrapartum HIV counseling and testing for prevention of mother-to-child transmission of HIV in a rural Ugandan hospital. J Acquir Immune Defic Syndr (2006) 2.67
Prevalence of transmitted drug resistance associated mutations and HIV-1 subtypes in new HIV-1 diagnoses, U.S.-2006. AIDS (2010) 2.62
Desire for children and pregnancy risk behavior among HIV-infected men and women in Uganda. AIDS Behav (2006) 2.59
Home-based model for HIV voluntary counselling and testing. Lancet (2003) 2.57
HIV prevention for a threatened continent: implementing positive prevention in Africa. JAMA (2006) 2.51
Antiretroviral therapy improves renal function among HIV-infected Ugandans. Kidney Int (2008) 2.49
The estimated direct medical cost of selected sexually transmitted infections in the United States, 2008. Sex Transm Dis (2013) 2.39
CD4+ T-cell count monitoring does not accurately identify HIV-infected adults with virologic failure receiving antiretroviral therapy. J Acquir Immune Defic Syndr (2008) 2.32
Risk factor redistribution of the national HIV/AIDS surveillance data: an alternative approach. Public Health Rep (2008) 2.32
Proportions of Kaposi sarcoma, selected non-Hodgkin lymphomas, and cervical cancer in the United States occurring in persons with AIDS, 1980-2007. JAMA (2011) 2.31
U.S. trends in antiretroviral therapy use, HIV RNA plasma viral loads, and CD4 T-lymphocyte cell counts among HIV-infected persons, 2000 to 2008. Ann Intern Med (2012) 2.18
Uncertainties associated with incidence estimates of HIV/AIDS diagnoses adjusted for reporting delay and risk redistribution. Stat Med (2005) 2.15
Retention in care of adults and adolescents living with HIV in 13 U.S. areas. J Acquir Immune Defic Syndr (2012) 2.15
Effect of home-based water chlorination and safe storage on diarrhea among persons with human immunodeficiency virus in Uganda. Am J Trop Med Hyg (2005) 2.12
Rapid implementation of an integrated large-scale HIV counseling and testing, malaria, and diarrhea prevention campaign in rural Kenya. PLoS One (2010) 2.12
Lack of knowledge of HIV status a major barrier to HIV prevention, care and treatment efforts in Kenya: results from a nationally representative study. PLoS One (2012) 2.10
Vital Signs: Estimated Percentages and Numbers of Adults with Indications for Preexposure Prophylaxis to Prevent HIV Acquisition - United States, 2015. MMWR Morb Mortal Wkly Rep (2015) 2.05
Estimating per-act HIV transmission risk: a systematic review. AIDS (2014) 2.04
Depression and CD4 cell count among persons with HIV infection in Uganda. AIDS Behav (2006) 2.01
Ebola virus disease in health care workers--Sierra Leone, 2014. MMWR Morb Mortal Wkly Rep (2014) 1.99
Prevalence of Diagnosed and Undiagnosed HIV Infection--United States, 2008-2012. MMWR Morb Mortal Wkly Rep (2015) 1.99
Home-based HIV testing and counseling in rural and urban Kenyan communities. J Acquir Immune Defic Syndr (2013) 1.98
Clinical toxicity of highly active antiretroviral therapy in a home-based AIDS care program in rural Uganda. J Acquir Immune Defic Syndr (2007) 1.97
CD4 cell count and viral load monitoring in patients undergoing antiretroviral therapy in Uganda: cost effectiveness study. BMJ (2011) 1.96
The cost effectiveness of home-based provision of antiretroviral therapy in rural Uganda. Appl Health Econ Health Policy (2009) 1.94
Breast and cervical carcinoma screening practices among women in rural and nonrural areas of the United States, 1998-1999. Cancer (2002) 1.93
Building the infrastructure for nationwide cancer surveillance and control--a comparison between the National Program of Cancer Registries (NPCR) and the Surveillance, Epidemiology, and End Results (SEER) Program (United States). Cancer Causes Control (2003) 1.85
Characteristics of HIV infection among Hispanics, United States 2003-2006. J Acquir Immune Defic Syndr (2008) 1.79
HIV in persons born outside the United States, 2007-2010. JAMA (2012) 1.77
Cost-effectiveness of newborn circumcision in reducing lifetime HIV risk among U.S. males. PLoS One (2010) 1.77
Updated annual HIV transmission rates in the United States, 1977-2006. J Acquir Immune Defic Syndr (2009) 1.76
Prevalence of sunburn, sun protection, and indoor tanning behaviors among Americans: review from national surveys and case studies of 3 states. J Am Acad Dermatol (2011) 1.70
Factors associated with HIV infection in married or cohabitating couples in Kenya: results from a nationally representative study. PLoS One (2011) 1.68
Characteristics of persons with heterosexually acquired HIV infection, United States 1999-2004. Am J Public Health (2006) 1.66
Effect of cotrimoxazole on mortality in HIV-infected adults on antiretroviral therapy: a systematic review and meta-analysis. Bull World Health Organ (2011) 1.61
Trends in the population prevalence of people who inject drugs in US metropolitan areas 1992-2007. PLoS One (2013) 1.61
Sexual risk behaviour and viral suppression among HIV-infected adults receiving medical care in the United States. AIDS (2014) 1.61
Long-term experience providing antiretroviral drugs in a fee-for-service HIV clinic in Uganda: evidence of extended virologic and CD4+ cell count responses. J Acquir Immune Defic Syndr (2005) 1.59
Epidemiology of HIV in the United States. J Acquir Immune Defic Syndr (2010) 1.58
Estimating HIV incidence among adults in Kenya and Uganda: a systematic comparison of multiple methods. PLoS One (2011) 1.56
Home-based antiretroviral care is associated with positive social outcomes in a prospective cohort in Uganda. J Acquir Immune Defic Syndr (2007) 1.52
Use of a nationwide call center for Ebola response and monitoring during a 3-day house-to-house campaign - Sierra Leone, September 2014. MMWR Morb Mortal Wkly Rep (2015) 1.52
Changes in lipid profile over 24 months among adults on first-line highly active antiretroviral therapy in the home-based AIDS care program in rural Uganda. J Acquir Immune Defic Syndr (2008) 1.51
The role of bathhouses and sex clubs in HIV transmission: findings from a mathematic model. J Acquir Immune Defic Syndr (2007) 1.50
A way forward: the National HIV/AIDS Strategy and reducing HIV incidence in the United States. J Acquir Immune Defic Syndr (2010) 1.48
Late HIV diagnosis and determinants of progression to AIDS or death after HIV diagnosis among injection drug users, 33 US States, 1996-2004. PLoS One (2009) 1.48
HIV-infected ugandan adults taking antiretroviral therapy with CD4 counts >200 cells/μL who discontinue cotrimoxazole prophylaxis have increased risk of malaria and diarrhea. Clin Infect Dis (2012) 1.45
Racial/ethnic disparities in HIV diagnoses among persons aged 50 years and older in 37 US States, 2005-2008. Am J Public Health (2012) 1.44
Progress along the continuum of HIV care among blacks with diagnosed HIV- United States, 2010. MMWR Morb Mortal Wkly Rep (2014) 1.43
HIV diagnoses and prevalence in the southern region of the United States, 2007-2010. J Community Health (2013) 1.42
Association between transfusion with human herpesvirus 8 antibody-positive blood and subsequent mortality. J Infect Dis (2012) 1.42
Improving burial practices and cemetery management during an Ebola virus disease epidemic - Sierra Leone, 2014. MMWR Morb Mortal Wkly Rep (2015) 1.39
Breastfeeding, mother-to-child HIV transmission, and mortality among infants born to HIV-Infected women on highly active antiretroviral therapy in rural Uganda. J Acquir Immune Defic Syndr (2010) 1.38
Association between malaria and CD4 cell count decline among persons with HIV. J Acquir Immune Defic Syndr (2006) 1.35
Nonadherence to breast and cervical cancer screening: what are the linkages to chronic disease risk? Prev Chronic Dis (2003) 1.35
The estimated burden of HIV/AIDS in Uganda, 2005-2010. AIDS (2008) 1.34
Jurisdiction level differences in HIV diagnosis, retention in care, and viral suppression in the United States. J Acquir Immune Defic Syndr (2014) 1.33
HIV infection and older Americans: the public health perspective. Am J Public Health (2012) 1.31
Determining eligibility for antiretroviral therapy in resource-limited settings using total lymphocyte counts, hemoglobin and body mass index. AIDS Res Ther (2007) 1.30
Rapid assessment of Ebola infection prevention and control needs--six districts, Sierra Leone, October 2014. MMWR Morb Mortal Wkly Rep (2014) 1.30
Feasibility and effectiveness of cotrimoxazole prophylaxis for HIV-1-infected adults attending an HIV/AIDS clinic in Uganda. J Acquir Immune Defic Syndr (2006) 1.29
Skin cancer screening among U.S. adults from 1992, 1998, and 2000 National Health Interview Surveys. Prev Med (2004) 1.28
The epidemic of non-Hodgkin lymphoma in the United States: disentangling the effect of HIV, 1992-2009. Cancer Epidemiol Biomarkers Prev (2013) 1.27
Using the HIV surveillance system to monitor the National HIV/AIDS Strategy. Am J Public Health (2012) 1.27
Patient-delivered partner treatment for Trichomonas vaginalis infection: a randomized controlled trial. Sex Transm Dis (2006) 1.26
Sexual behavior and HIV transmission risk of Ugandan adults taking antiretroviral therapy: 3 year follow-up. AIDS (2011) 1.25
Collection of social determinant of health measures in U.S. national surveillance systems for HIV, viral hepatitis, STDs, and TB. Public Health Rep (2011) 1.25
Peer referral for HIV case-finding among men who have sex with men. AIDS (2006) 1.25
Trends in HIV prevalence and HIV testing among young MSM: five United States cities, 1994-2011. AIDS Behav (2014) 1.22